Navigation Links
Keeping the Data Center Clean: ATEN Launches Industry-First KVM Switches with Antimicrobial Nanocoating to Protect Products from Bacteria Surviving on Surfaces
Date:9/10/2007

rol of matter at dimensions of roughly 1 to 100 nanometers, where unique phenomena enable novel applications.

Available now, the following ATEN products will be the first KVM switches to offer the protective antimicrobial nanocoating:

-- KL9108M/KL9116M Hideaway(TM) LCD Console Over the NET -- In addition to

nanocoating, these products are Hideaway LCD IP-based KVM control units

that allow both local and remote operators to monitor and access

multiple computers from multiple consoles. A single KL9108M / KL9116M

can control up to 8 / 16 computers and can be accessed from any

computer via a web browser. The KL9108M / KL9116M features

independently retractable 17" LCD monitor and keyboard with built-in

touchpad. To maximize space in your data center, the keyboard "hides

away" when not in use. These nanocoated models are priced at $3195.95

and $3699.95, respectively.

-- KL1116L & KL1116M Hideaway(TM) LCD KVM Switch is a 16-port KVM unit

that allows access to multiple computers from a single 15" or 17" LCD

console. The model sports an innovative dual-rail design that allows

the console to slide back while the LCD panel remains in plain sight --

even with the server rack door closed -- to monitor and troubleshoot

servers. The KL1116 features the KH0116 KVM device built into this LCD.

The KL1116 nanocoated model is competitively priced at $2499.95 for

KL1116L and $2599.95 for KL1116M.

-- KL3116M is a rackmount 17" LCD KVMP (Keyboard, Video, Mouse,

Peripheral) switch that features an extra local console port, USB

peripheral sharing technology, and an external mouse port. The KL3116,

part of the ALTUSEN line of enterprise-class KVM solutions from ATEN,

is a 16-port switch that can monitor up to 16 computers in a 1U-high

configuration. The unit also includes dual
'/>"/>

SOURCE ATEN Technology, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Annual Meeting of the Consortium of Multiple Sclerosis Centers Focuses on the Challenges of Care and Research in Multiple Sclerosis
2. Breaking Multi-Center Study: Masimo SET Pulse Oximetry Technology Shown to Significantly Lower Instances of Severe Retinopathy of Prematurity in Extremely Low Birth Weight Infants
3. M. D. Anderson Cancer Center Researchers to Present CTCE-9908 Data at the AACR Annual Meeting
4. July Issue of Journal of Antimicrobial Chemotherapy Highlights Study of Factive Tablets for Five-Day Treatment of Community-Acquired Pneumonia
5. RTA 402 Shown to Protect Animals Against Toxicities of Standard Cancer Treatments
6. Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix Provides Excellent Protection Against Lesions Caused by Most Common Cancer-Causing Virus Types
7. New Study Shows That telmisartan has Greater Renoprotective Potential Thanlosartan in Hypertensive Patients With Type 2 Diabetes
8. Novavax Pandemic Flu Vaccine Provided Protection Against a Lethal Challenge of Live Virus, Pre-Clinical Data Show
9. Vaxfectin-formulated Measles DNA Vaccine Elicits Long-term Protection and Sterilizing Immunity in Nonhuman Primates
10. VGX Pharmaceuticals Novel HIV and Pandemic Influenza DNA Vaccine Candidates Trigger Robust Immune Responses and Protection in Pre-Clinical Models
11. AGI Dermatics Presents Comparative Data That Indicates OCTN-1 Skin Cells Have the Ability to Recognize, Transport and Utilize L-ergothioneine (EGT) As A Protector Against Oxidative Damage
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... Today, Hill-Rom Holdings, Inc. (NYSE: ... on significant strategic and financial initiatives at its ... Conference is hosted by Peter H. Soderberg, president ... on the following topics: ,, Status of ... development and financial updates Smart technologies that ...
(Date:12/15/2009)... Rib-X Pharmaceuticals, Inc., a company focused ... drugs for the treatment of serious multi-drug-resistant infections ... research agreement with Massachusetts General Hospital (MGH). ... collaboration, Dr. David Hooper of MGH will evaluate ... model to determine resistance development and to validate ...
(Date:12/15/2009)... SAN DIEGO, INDIANAPOLIS, and CAMBRIDGE, Mass., Dec. 15 ... AMLN ), Eli Lilly and Company (NYSE: ... ALKS ) today announced positive results from ... investigational diabetes therapy, to BYETTA® (exenatide) injection taken ... After 24 weeks of treatment, patients taking exenatide ...
Breaking Medicine Technology:Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies 2Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies 3Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies 4Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies 5Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies 6Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies 7Rib-X Pharmaceuticals Enters into Collaborative Agreement on Delafloxacin with Massachusetts General Hospital 2Rib-X Pharmaceuticals Enters into Collaborative Agreement on Delafloxacin with Massachusetts General Hospital 3Exenatide Once Weekly Provided Superior Glucose Control Compared to BYETTA(R) in DURATION-5 Study 2Exenatide Once Weekly Provided Superior Glucose Control Compared to BYETTA(R) in DURATION-5 Study 3Exenatide Once Weekly Provided Superior Glucose Control Compared to BYETTA(R) in DURATION-5 Study 4Exenatide Once Weekly Provided Superior Glucose Control Compared to BYETTA(R) in DURATION-5 Study 5Exenatide Once Weekly Provided Superior Glucose Control Compared to BYETTA(R) in DURATION-5 Study 6Exenatide Once Weekly Provided Superior Glucose Control Compared to BYETTA(R) in DURATION-5 Study 7First Defense Nasal Screen Comp Releases New Protection Product Just in Time for Pandemic Flu Season 55643 1First Defense Nasal Screen Comp Releases New Protection Product Just in Time for Pandemic Flu Season 55643 2First Defense Nasal Screen Comp Releases New Protection Product Just in Time for Pandemic Flu Season 55643 3First Defense Nasal Screen Comp Releases New Protection Product Just in Time for Pandemic Flu Season 55643 4Waismann Method Offers Safe Treatment for Dependency to Benzodiazepines 55641 1Waismann Method Offers Safe Treatment for Dependency to Benzodiazepines 55641 2Waismann Method Offers Safe Treatment for Dependency to Benzodiazepines 55641 3Watson Pharmaceuticals Receives FDA Approval for Generic PLAN B 28R 29 for Over the Counter Use 55640 1Watson Pharmaceuticals Receives FDA Approval for Generic PLAN B 28R 29 for Over the Counter Use 55640 2
... U.S.-based subsidiary of,Pharmexa A/S, presents selected data ... Influenza Conference entitled, "Options for,the Control of ... The,data show that a "universal" vaccine designed ... mice against,lethal experimental influenza virus challenge. , ...
... SAN FRANCISCO & NEW DELHI, India--(BUSINESS WIRE)--Jun 21, ... non-profit,pharmaceutical company, today announced that Phase 3 research,related ... (Paromomycin), was published in the current issue of ... trial shows,that the medicine paromomycin is safe, effective, ...
Other Medicine Technology:Pharmexa A/S (DK) - Pharmexa presents data from influenza program 2Research on New Treatment for Neglected Disease Published in The,New England Journal of Medicine 2Research on New Treatment for Neglected Disease Published in The,New England Journal of Medicine 3Research on New Treatment for Neglected Disease Published in The,New England Journal of Medicine 4
(Date:12/15/2009)... SAN DIEGO, Dec. 15 "The entire San ... mourns the passing of Sol Price on December 14, ... standards of integrity, loyalty and ethics in his business, ... and thoughtful humanitarian who truly understood the responsibility of ... and his legacy will live on through his countless ...
(Date:12/15/2009)... A study in the Dec. 15 issue of ... indicates that significant associations exist between parent-reported insomnia ... headaches in young school-aged children. , Results ... was 3.3 times more likely in children with ... children with headaches. Nineteen percent of children ...
(Date:12/14/2009)... Research Focuses on Unmarried Young Adults, Attitudes and Behavior ... WASHINGTON, Dec. 15 Nearly all unmarried young ... be planned (94% of men and 86% of women) ... in their lives right now (86% of men and ... The National Campaign to Prevent Teen and Unplanned Pregnancy. ...
(Date:12/14/2009)... particles carry oxygen, drugs, and more… , ... ... Santa Barbara, in collaboration with scientists at University of Michigan, ... key functions of natural red blood cells, including softness, flexibility, ... , ,The primary function of natural red blood cells is ...
(Date:12/14/2009)... Mich., Dec. 14 Pepsi Bottling ... Commonwealth of Kentucky are among the major employers ... fall to help their employees make better decisions ... gives employees a personalized summary of their families, ... that care. With this personalized information, employees can ...
Breaking Medicine News(10 mins):Health News:San Diego Hospice and The Institute for Palliative Medicine on the Passing of Sol Price 2Health News:Insomnia symptoms linked with medical complaints in young school-aged children 2Health News:Insomnia symptoms linked with medical complaints in young school-aged children 3Health News:Although Most Unmarried Young Adults Want to Avoid Pregnancy, Many Don't Use Contraception, Know Little About It, and Think It Doesn't Make Much Difference 2Health News:Although Most Unmarried Young Adults Want to Avoid Pregnancy, Many Don't Use Contraception, Know Little About It, and Think It Doesn't Make Much Difference 3Health News:Synthetic Red Blood Cells Developed 2Health News:Synthetic Red Blood Cells Developed 3Health News:Corporations, Universities and State Governments Deploy Thomson Reuters Solution to Improve Employees' Benefit Selection Process 2
... controls the rapid production and differentiation of the stem cells that ... open the door to more streamlined treatments for leukemia and other ... , ... (Vocus) April 8, 2009 -- Researchers have identified ...
... IMRIS Inc. (TSX: IM) ("IMRIS" or the "Company") participated ... at PLA 301 Hospital in Beijing on April 5, ... and Hong Kong attended the inaugural event that focused ... was opened by Dir Chen Xiaohong, Director of PLA ...
... Leadership Conference on April 24 ALEXANDRIA, Va., April 8 ... president and CEO, joined an invitation-only meeting at the ... appointed Director of the White House Office of Health ... to this important meeting is an indicator of the ...
... AJ,s grocery stores sell limited-edition, reusable grocery totes to ... age-old question of "paper or plastic" by choosing to ... Children,s Hospital. Bashas, Food City and AJ,s grocery stores ... Shamrock Farms on a charitable "green" mission this spring. ...
... drug lowers prostate specific antigen (PSA) levels a ... prostate cancer for whom traditional treatment options have failed. ... Center (MSKCC), is published today in Science ... ., Most men with metastatic prostate cancer eventually build ...
... Cancer Researchers and Updates on Key Discoveries, Plus ... April 8 Internationally renowned physician-scientists will discuss ... US, plus important recent discoveries in translational cancer ... Cancer Research Foundation Clinical Investigator Symposium.The ...
Other Medicine News:Health News:Scientists Identify Key Gene That Protects Against Leukemia 2Health News:Scientists Identify Key Gene That Protects Against Leukemia 3Health News:Scientists Identify Key Gene That Protects Against Leukemia 4Health News:Neurosurgeons from around the world gather at PLA 301 Hospital in China 2Health News:NHPCO President/CEO Meets with Nancy-Ann Min DeParle at White House 2Health News:Hometown Grocer, Local Food Companies Team up to Support Pediatric Patients, Encourage 'Green' Lifestyle 2Health News:Hometown Grocer, Local Food Companies Team up to Support Pediatric Patients, Encourage 'Green' Lifestyle 3Health News:Hometown Grocer, Local Food Companies Team up to Support Pediatric Patients, Encourage 'Green' Lifestyle 4Health News:Drug shows activity in men with advanced prostate cancer 2Health News:Drug shows activity in men with advanced prostate cancer 3Health News:Top Physician-Scientists Discuss State of Cancer Research at Damon Runyon Cancer Research Foundation Symposium 2Health News:Top Physician-Scientists Discuss State of Cancer Research at Damon Runyon Cancer Research Foundation Symposium 3Health News:Top Physician-Scientists Discuss State of Cancer Research at Damon Runyon Cancer Research Foundation Symposium 4
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: